1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Identifying New Antimigraine Targets : Lessons from Molecular Biology (
- Subacute phase of subarachnoid haemorrhage in female rats : Increased intracranial pressure, vascular changes and impaired sensorimotor function (
- 2020
- Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies (
- Differences in pituitary adenylate cyclase-activating peptide and calcitonin gene-related peptide release in the trigeminovascular system (
- 2019
- Does inflammation have a role in migraine? (
- MEK/ERK/1/2 sensitive vascular changes coincide with retinal functional deficit, following transient ophthalmic artery occlusion (
- Exploration of Physiological and Pathophysiological Implications of miRNA-143 and miRNA-145 in Cerebral Arteries (
- 2018
- CGRP as the target of new migraine therapies — successful translation from bench to clinic (
- 2016
- Enhanced endothelin-1 mediated vasoconstriction of the ophthalmic artery may exacerbate retinal damage after transient global cerebral ischemia in rat (
- 2014
- Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds (